These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 25145705)
1. Transducin β-like 1 X-linked receptor 1 suppresses cisplatin sensitivity in nasopharyngeal carcinoma via activation of NF-κB pathway. Chen SP; Yang Q; Wang CJ; Zhang LJ; Fang Y; Lei FY; Wu S; Song LB; Guo X; Guo L Mol Cancer; 2014 Aug; 13():195. PubMed ID: 25145705 [TBL] [Abstract][Full Text] [Related]
2. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition. Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847 [TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer. Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172 [No Abstract] [Full Text] [Related]
4. BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer. Kuang CM; Fu X; Hua YJ; Shuai WD; Ye ZH; Li Y; Peng QH; Li YZ; Chen S; Qian CN; Huang W; Liu RY Cell Death Dis; 2017 Jun; 8(6):e2874. PubMed ID: 28617432 [TBL] [Abstract][Full Text] [Related]
5. TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer. Zhang T; Liu C; Yu Y; Geng J; Meng Q; Xu S; Zhou F; Chen Y; Jin S; Shen J; Pan B; Meng F; Liu F Cancer Gene Ther; 2020 Apr; 27(3-4):136-146. PubMed ID: 31243347 [TBL] [Abstract][Full Text] [Related]
6. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway. Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893 [TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis. Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278 [TBL] [Abstract][Full Text] [Related]
9. Correlations between TBL1XR1 and recurrence of colorectal cancer. Liu H; Xu Y; Zhang Q; Li K; Wang D; Li S; Ning S; Yang H; Shi W; Liu Z; Chen Y Sci Rep; 2017 Mar; 7():44275. PubMed ID: 28295012 [TBL] [Abstract][Full Text] [Related]
10. Chitinase 3 like-1 activates the Akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells. Li D; Fan G; Zhou Y Cytokine; 2024 Jul; 179():156631. PubMed ID: 38710115 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma. Cao JY; Liu L; Chen SP; Zhang X; Mi YJ; Liu ZG; Li MZ; Zhang H; Qian CN; Shao JY; Fu LW; Xia YF; Zeng MS Mol Cancer; 2010 Sep; 9():237. PubMed ID: 20828406 [TBL] [Abstract][Full Text] [Related]
12. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280 [TBL] [Abstract][Full Text] [Related]
13. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells. Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337 [No Abstract] [Full Text] [Related]
14. MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-κB. Shi Z; Hu Z; Chen D; Huang J; Fan J; Zhou S; Wang X; Hu J; Huang F Mol Med Rep; 2016 Feb; 13(2):1732-8. PubMed ID: 26718506 [TBL] [Abstract][Full Text] [Related]
15. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507 [TBL] [Abstract][Full Text] [Related]
16. A positive feedback loop between PLD1 and NF-κB signaling promotes tumorigenesis of nasopharyngeal carcinoma. Zhou YQ; Cheng XX; He S; Liu SQ; Li YQ; Wei PP; Luo CL; Bei JX J Genet Genomics; 2024 Oct; 51(10):997-1006. PubMed ID: 38885836 [TBL] [Abstract][Full Text] [Related]
17. TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer. Liu H; Liu Z; Li K; Li S; Song L; Gong Z; Shi W; Yang H; Xu Y; Ning S; Ismail S; Chen Y J Gastroenterol Hepatol; 2017 Sep; 32(9):1570-1580. PubMed ID: 28127799 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway. Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592 [TBL] [Abstract][Full Text] [Related]
19. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway. Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771 [TBL] [Abstract][Full Text] [Related]
20. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer. Ma M; Yu N Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]